CHIP has also been independently associated with MASLD-related hepatocellular carcinoma (HCC), with mutations in non-DNMT3A drivers, notably TET2 and TP53, showing the strongest associations [97]. This evidence concerns the gene TP53 and hepatocellular carcinoma.